Abstract: Effective gene therapy requires efficient delivery of DNA to transfected cells followed by high levels of gene expression. Our laboratory has developed two new delivery formulations LPDI containing the DNA condensing agent protamine sulfate and reconstitued chylomicrons containing a hydrophobic lipidDNA complex. LPDI can produce higher levels of gene expression than the corresponding liposome/DNA complexes alone both in vitro and in vivo. Reconstituted chylomicrons also induce high gene expression in the liver through intraportal injection. To increase overall gene expression of delivered DNA, an improved cytoplasmic expression system has been developed using a unique T7 RNA polymerase autogene pCMVIT7-T7pol. High levels of reporter gene expression were detected in the presence of this new autogene.
as LPDI (ref. 4) and reconstituted chylomicrons have been developed in our laboratory. The current, improved version of LPDI consists of a cationic peptide, protamine sulfate, which condenses the DNA to form a DNNpolycation complex before the addition of cationic liposomes such as DOTAP to increase transfection efficiency both in vitro and in vivo (ref.
5-6).
On the other hand, a hydrophobic lipid (TC-chol)DNA complex can be incorporated into reconstituted chylomicrons by emulsifying with a mixture of trigylcerides, phospholipid and cholesterol to reduce serum sensitivity (ref. 7) . The latter formulation also could be targeted to specific tissues for gene delivery.
Another major obstacle in gene therapy is inefficient expression of transfected DNA due to low nuclear transport where transcription machinery resides (ref. [8] [9] . Since the addition of a nuclear localization signal had limited success (ref. lo), a cytoplasmic expression system was developed to express DNA in the cytoplasm of transfected cells. ExogenousT7 RNA polymerase enzyme when delivered with a reporter gene driven by the T7 bacteriophage promoter can induce cytoplasmic reporter gene expression due to the lack of a nuclear localization signal in T7 RNA polymerase (ref. [11] [12] [13] . This had led to the development of several T7 RNA polymerase autogenes made up of a T7 RNA polymerase gene driven by the T7 promoter to continuously supply transfected cells with high levels of endogenous T7 RNA polymerase (ref. [14] [15] [16] [17] . A novel T7 RNA polymerase autogene, pCMV/T7-T7pol, developed in our laboratory has been shown to induce higher, more sustained cytoplasmic reporter gene expression than previous autogenes or that found with a nuclear expression system driven by the cytomegalovirus promoter CMV and does not require exogenous T7 RNA polymerase enzyme.
LPDIparticles containing protarnine for enhanced in vifro and in vivo transfection efficiency Polycations such as poly-L-lysine condense DNA into polycatiodDNA complexes and when combined with cationic liposomes, can enhance gene expression over that seen with cationic lipid/DNA complexes alone (ref. 4). These LPDI particles were hypothesized to have a higher transfection efficiency for several reasons: 1) LPDI are highly compacted particles (50-75 nm in size) to assist in eficient cellular and nuclear uptake, 2) condensation of DNA protects against enzymatic digestion, 3) poly-L-lysine may mimic the nuclear localization signal to assist DNA delivery to the nucleus.
Our laboratory has investigated an alternative polycation to be used in LPDI. Protamine sulfate from salmon sperm is a small (MW-4000), highly postively charged peptide due to the presence of 21 arginine residues which contains a nuclear localization signal (ref. 18). Protamine sulfate can induce higher levels of gene expression than poly-L-lysine and other types of protamines when combined with DNA and DCcho1:DOPE cationic liposomes (ref. 5). As shown in Fig. 1 , poly-L-lysine did enhance gene expression of a pCMV-Luciferase plasmid over that seen with DNA/DC-cho1:DOPE liposomes alone by 60-fold in CHO cells. However, the protamine sulfates induced an even higher levels of gene expression which was 3-5 fold higher than expression with poly-L-lysine, Though minimal luciferase expression was observed with protamine phosphate and free base, protamine chloride produced high levels of gene expression but were still inferior to expression with protamine sulfate. This seems to be due to higher DNA condensation with protamine sulfate as seen in ethidium bromide displacement studies (ref. 
Comparison of different polycations for enhancement of Various types of protamine
Protamine sulfate was also compared with poly-L-lysine, protamine free base and protamine phosphate polycations in vivo by forming LPD particles with pCMV-Luciferase DNA and DOTAP liposomes at a protamine/DNA/DOTAP charge ratio of 1/1/11 (ref. 6 , Fig. 2 ). Intravenous injection into mice showed that protamine sulfate induced the highest gene expression over all the polycations used and over that seen w i t h DOTAP cationic liposome/DNA complexes alone. Gene expression was highest in the lung and spleen when injected intravenously as seen in Fig. 2 Fig. 3 ). High levels of luciferase expression were detected in liver, spleen, lung, kidney and heart with the highest levels seen in the liver. Expression levels in the liver with reconstituted chylomicrons were almost 100 times higher than injections with naked DNA. 8-9 ). Cytoplasmic expression systems utilizing T7 RNA polymerase were developed to avoid nuclear delivery and take advantage of the high levels of DNA in the cytoplasm. Many autogenes have been desinged to express the T7 RNA polymerase gene in the cytoplam via its own T7 promoter (ref. [14] [15] [16] [17] . Therefore, these autogenes work to continously produce T7 RNA polymerase in the cytoplasm to then drive expression of trangenes carrying the T7 promoter. These autogenes did improve expression levels, however, several problems still remained. These auotgenes were difficult to amplify and purify from bacteria. They still required the addition of exogenous T7 RNA polymerase to induce initial expression from the autogene which is expensive and possibly immunogenic. Finally, expression levels still remained low and only lasted a few days. One example of these autogenes is pT7 AUTO 2 C (Fig. 4A) . When this autogene is co-delivered with exogenous T7 RNA polymerase enzyme to cells through endocytosis (l), they are released from endosomes into the cytoplasm (2). pT7 AUTO 2 C is then transcribed by the exogenousT7 RNA polymerase enzyme and translated in the cytoplasm (3). The resulting endogenous T7 RNA polymerase then recognizes the T7 promoter on the autogene to induce hrther transcriptiodtranslation of T7 RNA polymerase.
Our laboratory has constructed a new T7 RNA polymerase autogene, pCMV/T7-T7pol, which avoids the problems associated with the previously used autogenes. It consists of a T7 RNA polymerase gene driven by a cytomegalovirus (CMV) promoter and a T7 bacteriophage promoter (Fig. 4B) . When this autogene enters the cell through endocytosis (l), the pCMV/T7-T7pol is released from endosomes (2) to allow a small amount of DNA to enter the nucleus (3). This allows the first round of T7 RNA polymerase expression to begin in the nucleus driven by the CMV promoter (4) followed by translation in the cytoplasm (5). Only a small amount of the nuclear derived T7 RNA polymerase needs to be present to initiate expression of the autogene in the cytoplasm via the T7 promoter (6) . Cytoplasmic expression will then continue to produce high, sustained levels of T7 RNA polymerase to then drive transgene expression in the cytoplasm.
pCMV/T7-T7pol was co-delivered with pT7-CAT to 293 cells in the absence or presence of exogenous T7 RNA polymerase enzyme. This was compared with activities produced with a previously used autogene pT7 AUTO 2C-driven only by the T7 promoter under the same conditions. Comparison of CAT activities produced by different sources of pT7-CAT (1 pg) was co-transfected
As shown in Fig. 5 , pCMVIT7-T7pol produced higher levels of CAT activity than pT7 AUTO 2C-in the presence and absence of exogenous T7 RNA polymerase. pT7 AUTO 2C-only produced CAT activity in the presence of exogenousT7 RNA polymerase since it requires this enzyme to initiate expression at the autogene. pCMV/T7-T7pol can also produce higher CAT activity over longer periods of time (>7 days) than pT7 AUTO 2C-due to largerproduction of T7 RNA polymerase levels in the cytoplasm by pCMV/T7-T7pol detected by Western blot analysis (data not shown). pCMV/T7-T7pol can also induce CAT activities higher than that seen with a nuclear expression system pCMV-CAT (Fig.  5) . Therefore, pCMV/T7-T7pol could replace exisiting autogenes for high, sustained cytoplasmic expression of transgenes.
